We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Noncardiac Chest Pain and Proton Pump Inhibitors—Reply

Ronnie Fass, MD; Benjamin C. Y. Wong, MD
Arch Intern Med. 2006;166(2):248-249. doi:10.1001/archinte.166.2.248-b.
Text Size: A A A
Published online


In reply

We disagree with many of the concerns that Numans raised and would like to discuss the meta-analysis by him and his colleagues.1 Understanding the physiologic features of nonerosive reflux disease would have identified the limitation of the PPI test in patients with GERD that resulted in attenuated conclusions. In these trials, the PPI test is compared with a combination of 24-hour esophageal pH testing and upper endoscopy. As a result, patients excluded by the PPI test are those with functional heartburn (typical heartburn but normal endoscopy and 24-hour pH monitoring). However, as Numans et al1 have found, the sensitivity of the PPI test in GERD was relatively high, but the specificity was low. This is primarily because a subset of patients with functional heartburn responded to PPI therapy. Up to 50% of patients with functional heartburn respond to treatment with PPIs once a day,2 with an even better response to higher doses of PPIs.3 In fact, the meta-analysis by Numans et al1 provides support for the PPI test because of its capability of diagnosing functional heartburn that is responsive to antireflux medications. This was clearly not taken into consideration.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
PubMed Articles